Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Porcine Galectin-3 ELISA Kit (AC3119)
Cat.#: ASET-1708
Specifications
Description Porcine Galectin-3 ELISA Kit allows for the in vitro quantitative determination of porcine Galectin-3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Porcine Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1263 Human GPR37L1 ELISA Kit (AC2674) Quantitative inquiry ASET-2524 Rat VEGFB ELISA Kit (AC3935) Quantitative inquiry ASET-1777 Human Drebrin ELISA Kit (AC3188) Quantitative inquiry ASET-1507 Human Jagged1 ELISA Kit (AC2918) Quantitative inquiry ASET-2170 Rat Dopamine Receptor D1 ELISA Kit (AC3581) Quantitative inquiry ASET-2512 Rat Oxytocin ELISA Kit (AC3923) Quantitative inquiry ASET-2076 Human EDG8 ELISA Kit (AC3487) Quantitative inquiry ASET-2243 Human Dopamine Receptor D1 ELISA Kit (AC3654) Quantitative inquiry ASET-2475 Human PMP22 ELISA Kit (AC3886) Quantitative inquiry ASET-1478 Mouse Mitofusin 2 ELISA Kit (AC2889) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket